BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27460695)

  • 1. Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin-1 (CAV-1) pathway.
    Vellecco V; Mitidieri E; Gargiulo A; Brancaleone V; Matassa D; Klein T; Esposito F; Cirino G; Bucci M
    Diabetes Obes Metab; 2016 Dec; 18(12):1236-1243. PubMed ID: 27460695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
    Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
    Jyoti U; Kansal SK; Kumar P; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways.
    Shah Z; Pineda C; Kampfrath T; Maiseyeu A; Ying Z; Racoma I; Deiuliis J; Xu X; Sun Q; Moffatt-Bruce S; Villamena F; Rajagopalan S
    Vascul Pharmacol; 2011; 55(1-3):2-9. PubMed ID: 21397040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway.
    Hsieh MJ; Lee CH; Chueh HY; Chang GJ; Huang HY; Lin Y; Pang JS
    Sci Rep; 2020 Oct; 10(1):17078. PubMed ID: 33051481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle.
    Ling WC; Lau YS; Murugan DD; Vanhoutte PM; Mustafa MR
    Vascul Pharmacol; 2015 Nov; 74():87-92. PubMed ID: 26044183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice.
    Sun HJ; Ni ZR; Liu Y; Fu X; Liu SY; Hu JY; Sun QY; Li YC; Hou XH; Zhang JR; Zhu XX; Lu QB
    Cardiovasc Diabetol; 2024 Apr; 23(1):138. PubMed ID: 38664801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Kolibabka M; Dietrich N; Klein T; Hammes HP
    Diabetologia; 2018 Nov; 61(11):2412-2421. PubMed ID: 30097694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose.
    Salheen SM; Panchapakesan U; Pollock CA; Woodman OL
    Pharmacol Res; 2015 Apr; 94():26-33. PubMed ID: 25697548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy.
    Hasan AA; von Websky K; Reichetzeder C; Tsuprykov O; Gaballa MMS; Guo J; Zeng S; Delić D; Tammen H; Klein T; Kleuser B; Hocher B
    Kidney Int; 2019 Jun; 95(6):1373-1388. PubMed ID: 30979564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
    Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.
    Pojoga LH; Yao TM; Opsasnick LA; Garza AE; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2014 Feb; 348(2):260-70. PubMed ID: 24281385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.
    Sato H; Kubota N; Kubota T; Takamoto I; Iwayama K; Tokuyama K; Moroi M; Sugi K; Nakaya K; Goto M; Jomori T; Kadowaki T
    Diabetologia; 2016 Nov; 59(11):2426-2434. PubMed ID: 27525648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation.
    Smimmo M; Casale V; Casillo GM; Mitidieri E; d'Emmanuele di Villa Bianca R; Bello I; Schettino A; Montanaro R; Brancaleone V; Indolfi C; Cirino G; Di Lorenzo A; Bucci M; Panza E; Vellecco V
    Biomed Pharmacother; 2024 May; 174():116466. PubMed ID: 38552439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
    Ishii M; Shibata R; Kondo K; Kambara T; Shimizu Y; Tanigawa T; Bando YK; Nishimura M; Ouchi N; Murohara T
    J Biol Chem; 2014 Sep; 289(39):27235-27245. PubMed ID: 25100725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice.
    Manrique C; Habibi J; Aroor AR; Sowers JR; Jia G; Hayden MR; Garro M; Martinez-Lemus LA; Ramirez-Perez FI; Klein T; Meininger GA; DeMarco VG
    Cardiovasc Diabetol; 2016 Jul; 15():94. PubMed ID: 27391040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho-/- mice.
    Hasegawa Y; Hayashi K; Takemoto Y; Cheng C; Takane K; Lin B; Komohara Y; Kim-Mitsuyama S
    Cardiovasc Diabetol; 2017 Dec; 16(1):154. PubMed ID: 29195509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells.
    Meye C; Schumann J; Wagner A; Gross P
    Atherosclerosis; 2007 Feb; 190(2):256-63. PubMed ID: 16616146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.